BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21243392)

  • 1. Transient leukoencephalopathy after intrathecal methotrexate mimicking stroke.
    Agarwal A; Vijay K; Thamburaj K; Ouyang T
    Emerg Radiol; 2011 Aug; 18(4):345-7. PubMed ID: 21243392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient encephalopathy after intrathekal methotrexate chemotherapy: diffusion-weighted MRI.
    Küker W; Bader P; Herrlinger U; Heckl S; Nägele T
    J Neurooncol; 2005 May; 73(1):47-9. PubMed ID: 15933817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subacute methotrexate-related leukoencephalopathy with stroke-like presentation.
    Iwatani K; Fujii N; Deguchi S; Tanimoto M
    Int J Hematol; 2012 Dec; 96(6):683-4. PubMed ID: 23114968
    [No Abstract]   [Full Text] [Related]  

  • 4. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.
    Bhojwani D; Sabin ND; Pei D; Yang JJ; Khan RB; Panetta JC; Krull KR; Inaba H; Rubnitz JE; Metzger ML; Howard SC; Ribeiro RC; Cheng C; Reddick WE; Jeha S; Sandlund JT; Evans WE; Pui CH; Relling MV
    J Clin Oncol; 2014 Mar; 32(9):949-59. PubMed ID: 24550419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute methotrexate-related neurotoxicity and pseudo-stroke syndrome].
    Deneux V; Leboucq N; Saumet L; Haouy S; Akbaraly T; Sirvent N
    Arch Pediatr; 2017 Dec; 24(12):1244-1248. PubMed ID: 29146215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate leukoencephalopathy mimics acute progressive stroke.
    Tanaka R; Sasaki-Ikesawa K; Shimura H; Nishioka K; Hattori N; Tanaka S
    J Neurol; 2011 Nov; 258(11):2083-5. PubMed ID: 21512738
    [No Abstract]   [Full Text] [Related]  

  • 7. Repeated Episodes of Leukoencephalopathy after High-dose Methotrexate in a Child with Acute Lymphoblastic Leukemia.
    Tsao TF; Chao YH
    Indian Pediatr; 2017 Feb; 54(2):159. PubMed ID: 28285295
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurotoxicity of intrathecal methotrexate: MR imaging findings.
    Sandoval C; Kutscher M; Jayabose S; Tenner M
    AJNR Am J Neuroradiol; 2003 Oct; 24(9):1887-90. PubMed ID: 14561622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate-induced toxic leukoencephalopathy: an uncommon stroke mimic.
    Maas RPPWM; Pegge SAH; Evers D; van Samkar A; Klijn CJM
    Neurol Sci; 2019 Jun; 40(6):1307-1309. PubMed ID: 30637582
    [No Abstract]   [Full Text] [Related]  

  • 10. [Picture in clinical hematology no. 69--Case of asymptomatic limbic leukoencephalopathy due to methotrexate therapy].
    Kida J; Uemura M; Araya T; Matsumoto K; Imataki O; Takahashi T; Kimura N
    Rinsho Ketsueki; 2014 Jan; 55(1):1. PubMed ID: 24492028
    [No Abstract]   [Full Text] [Related]  

  • 11. A Stroke Mimic: A 14-Year-Old Cancer Patient Presenting With Acute Right-Sided Weakness.
    Thomas N; Alpern ER
    Pediatr Emerg Care; 2017 Mar; 33(3):210-212. PubMed ID: 28248761
    [No Abstract]   [Full Text] [Related]  

  • 12. A unique radiological case of intrathecal methotrexate-induced toxic leukoencephalopathy.
    Yang J; Kim GS; Park HM
    J Neurol Sci; 2015; 353(1-2):169-71. PubMed ID: 25912173
    [No Abstract]   [Full Text] [Related]  

  • 13. Characteristics of methotrexate-induced stroke-like neurotoxicity.
    Watanabe K; Arakawa Y; Oguma E; Uehara T; Yanagi M; Oyama C; Ikeda Y; Sasaki K; Isobe K; Mori M; Hanada R; Koh K
    Int J Hematol; 2018 Dec; 108(6):630-636. PubMed ID: 30182170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rare complication of intrathecal methotrexate in a child with acute lymphoblastic leukemia.
    Tufekci O; Yilmaz S; Karapinar TH; Gozmen S; Cakmakci H; Hiz S; Irken G; Oren H
    Pediatr Hematol Oncol; 2011 Sep; 28(6):517-22. PubMed ID: 21699468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI findings in methotrexate-induced acute toxic leukoencephalopathy.
    Jakkani RK; Krishna Reddy GV; Anasuri S; Suvarna H; Kumar MS; Satyanarayan S
    Neurol India; 2017; 65(6):1439-1440. PubMed ID: 29133739
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute methotrexate neurotoxicity with choreiform movements and focal neurological deficits: a case report.
    Bota DA; Dafer RM
    South Med J; 2009 Oct; 102(10):1071-4. PubMed ID: 19738521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlating pathology with the clinical symptoms of methotrexate-induced leukoencephalopathy in a child with relapsed T-cell acute lymphoblastic leukemia.
    Summers RJ; Abramowsky CR; Cooper TM
    J Pediatr Hematol Oncol; 2014 Jan; 36(1):e19-22. PubMed ID: 23274378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer.
    Inaba H; Khan RB; Laningham FH; Crews KR; Pui CH; Daw NC
    Ann Oncol; 2008 Jan; 19(1):178-84. PubMed ID: 17947226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate-induced acute toxic leukoencephalopathy.
    Salkade PR; Lim TA
    J Cancer Res Ther; 2012; 8(2):292-6. PubMed ID: 22842379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group (POG) P9605 (standard risk) and P9201 (lesser risk) acute lymphoblastic leukemia protocols (ACCL0131): a methotrexate consequence? A report from the Children's Oncology Group.
    Duffner PK; Armstrong FD; Chen L; Helton KJ; Brecher ML; Bell B; Chauvenet AR
    J Pediatr Hematol Oncol; 2014 Jan; 36(1):8-15. PubMed ID: 24345882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.